More interestingly, methylation levels of 38 CpGDMs were able to separate primary tumor tissue from normal breast tissue in patients with familial breast cancer mutation in the BRCA2 gene (pairs N4/T4, N5/T5, N11/T11) (Fig. 1D, Table S3). The gene discussed is BRCA2; the disease is breast carcinoma.